Taiwan TCM Pavilion Captivates Global Pharma Community
Evidence-Based Formulas and Global Partnerships Showcase Taiwan's Strength in Integrative Medicine
FRANKFURT, Germany – The Taiwan Traditional Chinese Medicine (TCM) Pavilion at CPHI Frankfurt 2025 opened to an impressive response, attracting pharmaceutical professionals and distributors globally interested in evidence-based herbal innovations and unique collaboration opportunities.
Showcasing Taiwan's Commitment to TCM
Organized by the Department of Chinese Medicine and Pharmacy under Taiwan's Ministry of Health and Welfare and implemented by the Taiwan Institute of Economic Research, the Pavilion highlights Taiwan's integrated approach to traditional medicine. This blend of rich clinical heritage and modern scientific validation, along with robust regulatory support, positions Taiwan as a leader in the global TCM landscape.
Featured on the CPHI Newsbeat Stage
On the first day of the CPHI event, the Pavilion was featured on the CPHI Newsbeat Stage, providing a platform for TIER to pitch Taiwan's innovative TCM model to international industry press. During this session, TIER introduced the audience to how Taiwan is redefining its TCM approach through groundbreaking science and innovation. This was followed by an engaging interview with Raman Sehgal, the host of the popular life sciences podcast Molecule to Market, with several media outlets present. This influential discussion underlined NRICM101, developed during the COVID-19 outbreak, as a prime example of Taiwan's strategy grounded in evidence and supported by peer-reviewed studies showing its effectiveness in minimizing severe health outcomes.
Leading Taiwanese Enterprises Representing TCM Excellence
The Pavilion highlights five leading Taiwanese enterprises, including Chuang Song Zong, Li Kang Biotech, Timing Pharmaceutical, Taiwan Three Mast, and Grape King Bio. Each of these companies embodies the dynamic spirit of Taiwan's TCM sector, excelling in research, innovative product development, and GMP-certified manufacturing services that cater to global markets.
Innovative Formulas with Global Impact
At the heart of the Pavilion is an impressive showcase of formulas developed by the National Research Institute of Chinese Medicine, particularly NRICM101 and NRICM102. These formulas feature multi-target pharmacological actions that are designed to inhibit viral activity, alleviate inflammation, and lower the risk of severe COVID-19 outcomes. Remarkably, users of NRICM102 have shown a 74% reduced mortality rate, highlighting Taiwan's significant potential in advancing TCM on a global scale.
International Collaboration for Global Health
Dr. Yi-Chang Su, Director of both the Department of Chinese Medicine and Pharmacy and the NRICM, commented, "Taiwan's blend of TCM with modern scientific practices continues to garner global interest. We are optimistic about cultivating partnerships that introduce trusted, evidence-based TCM solutions to broader markets." Throughout the exhibition, Pavilion representatives are engaging with pharmaceutical companies, regulatory professionals, and industry promotion organizations from Europe and the Americas to discuss potential collaboration aimed at enhancing global health through Taiwan's TCM model.
Frequently Asked Questions
What is the primary focus of Taiwan's TCM Pavilion at CPHI Frankfurt?
The Pavilion emphasizes Taiwan's strength in evidence-based TCM, showcasing innovative herbal solutions and fostering partnerships with global pharmaceutical professionals.
Which companies are featured at the Taiwan TCM Pavilion?
Five enterprises including Chuang Song Zong, Li Kang Biotech, Timing Pharmaceutical, Taiwan Three Mast, and Grape King Bio represent Taiwan's dynamic TCM sector.
What unique product examples are highlighted in the Pavilion?
NRICM101 and NRICM102 are key formulas showcased, recognized for their pharmacological actions that significantly reduce severe health outcomes related to viral infections.
What audience is the Pavilion aiming to attract?
The Pavilion seeks to engage pharmaceutical professionals, distributors, and regulatory authorities from around the world interested in collaborative opportunities in TCM.
How does Taiwan's TCM model integrate modern science?
By combining traditional medicine practices with modern scientific validation and regulatory support, Taiwan is reshaping how TCM is perceived and utilized globally.
